OpGen, Inc. provided revenue guidance for the year 2023. The company expects continue pursuing significant revenue growth opportunities, especially with Unyvero product sales and ARESiss services, both in the U.S. and internationally; expect global revenues from products, services and collaborations for 2023 to be in the range of approximately $4 million to $5 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.51 USD | +0.86% | -19.55% | -15.83% |
Apr. 24 | OpGen Gets Notice of Noncompliance From Nasdaq | MT |
Mar. 26 | Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading | MT |
1st Jan change | Capi. | |
---|---|---|
-15.83% | 4.39M | |
+60.85% | 55.07B | |
-1.64% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+12.16% | 26.28B | |
-20.65% | 18.93B | |
+7.06% | 13.03B | |
+28.46% | 12.26B | |
+26.44% | 12.21B |
- Stock Market
- Equities
- OPGN Stock
- News OpGen, Inc.
- OpGen, Inc. Provides Revenue Guidance for the Year 2023